Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants

Author(s):

Alexander J. Thompson, Kathy Jackson, Sara Bonanzinga, Sam A.L. Hall, Simon Hume, Gareth S. Burns, Vijaya Sundararajan, Dilip Ratnam, Miriam T. Levy, John Lubel, Amanda J. Nicoll, Simone I. Strasser, William Sievert, Paul V. Desmond, Meng C. Ngu, Marie Sinclair, Christopher Meredith, Gail Matthews, Peter A. Revill, Margaret Littlejohn, D. Scott Bowden, Jesse A. Canchola, Jason Torres, Philip Siew, Jasmin Lau, Benjamin La Brot, Alison Kuchta, Kumar Visvanathan

Details:

Hepatology Communications, Volume 7, Issue 8, 2023-08-01, Article number e0188

Article Link: Click here

Affiliations:

• University of Melbourne
• The University of Sydney
• Monash University
• La Trobe University
• Royal Melbourne Hospital
• Royal Prince Alfred Hospital
• St. Vincent's Hospital Melbourne
• Austin Health
• St. Vincent's Hospital Sydney
• Monash Health
• Concord Repatriation General Hospital
• Eastern Health
• Alfred Health
• Bankstown-Lidcombe Hospital
• Roche Molecular Systems
• Liverpool Hospital
• Novartis Pty Ltd.